FDA and the future of medicine: Advancing regenerative medicine options for patients with safety and science at the forefront

On November 16, 2017, the US FDA announced a policy framework for regenerative medicine, releasing two final and two draft guidance documents. These documents reflect the agency’s commitment to modernize the system to incorporate promising cell and gene therapies and provide a structure for these options to be introduced in a fast, effective, and safe

Claudia Zylberberg interviewed for ‘Marketing Matters’ on Sirius XM Business Radio

This past week, Akron Biotech’s CEO Claudia Zylberberg was interviewed for Marketing Matters, a Sirius XM Business Radio show. Dr. Zylberberg appeared on the November 1, 2017 show to discuss how Akron Biotechnology has leveraged offline opportunities together with their online presence to enhance their brand. Marketing Matters is hosted by Wharton Marketing Professor Barbara Kahn and

Proceedings from Regenerative Medicine Forum Workshop at the National Academies Released

On June 26, 2017, the National Academies of Sciences, Engineering and Medicine organized a workshop hosted by the Regenerative Medicine Forum afocused on manufacturing and quality aspects in cell therapies. Akron’s CEO, Dr. Claudia Zylberberg, co-chaired the workshop. This was a public event with the aim of discussing challenges and best practices associated with defining and measuring the quality

Akron participates in panel on human platelet lysate at AABB Annual Meeting

The 2017 Annual Meeting of the American Association of Blood Banks (AABB) took place from October 7 – 10, 2017 in San Diego, CA. Akron Biotechnology participated in a panel as part of the AABB/ISCT Joint Working Group, Pooled Human Platelet Lysate (pHPL) for Cell Therapies Manufacturing. The thrust for this meeting comes from the increasing prevalence and

Wearable textile bandage releases wound-healing drugs on demand

Multiple approaches have been described for achieving therapeutically-effective wound healing. Biological factors that induce stimulation of cells to trigger and enhance the healing process have been extensively studied, and recently, new approaches for their delivery have been the focus of a vast number of studies. Delivery issues inherent to wound dressings include the need to